About Spherix Global Insights
We help pharma and biotech leaders make confident, informed decisions by combining deep therapeutic expertise, AI-enabled execution, and providing the complete market view across physicians, patients, and payers.
Spherix was founded on a premise that has not changed: that the biggest commercial decisions in pharma and biotech require deep therapeutic expertise and a partner who knows the market as well as you do. We combine that expertise with independent insights from providers, patients, and payers to deliver a complete view of the market.
Every Spherix solution combines independent primary research with deep expertise. AI accelerates study design, data collection, analysis, and reporting, while our specialists provide the interpretation and commercial judgment that turn information into strategy.
Our teams work across providers, patients, and payers to build a complete understanding of the market. Rigorous methodology, operational excellence, and direct engagement with healthcare stakeholders ensure every insight is timely, credible, and actionable.
The result is market intelligence that goes beyond reporting. Spherix helps pharmaceutical and biotech leaders understand what is changing, why it matters, and what to do next.
19
Our research is cited by financial analysts, patient advocacy groups, professional organizations, and industry media – not because we produce the most data, but because we produce data that holds up when it matters most.
A note from our CEO
Spherix was founded in 2015 on a simple premise: the industry moves faster, and makes better decisions, when it has data it can actually trust. What has distinguished us ever since is a commitment to seeing the market as a whole – connecting the clinical, personal, and access-related factors that shape how a therapy performs in the real world. Today, 19 of the top 20 pharmaceutical and biotech organizations rely on that view to make confident decisions. Our research is gathered directly from physicians, patients, and payers, and interpreted by our own team of specialists – not outsourced, not generic. As the pace of change in our industry accelerates, what does not change is what makes an insight worth trusting: the history behind it, the expertise applied to it, and the quality of the data beneath it. Those are what Spherix has invested in for more than a decade, and why we are positioned to make rigorous, connected intelligence more accessible than ever.
What we believe
Guided by our core values
Independence is non-negotiable
Spherix's syndicated research is conducted independently of any single manufacturer's influence. That is deliberate – it is what makes our data usable in investor reviews and board conversations where sponsored research carries an asterisk.
Depth over breadth
The complete picture requires three perspectives
Provider, patient, and payer dynamics are distinct forces that rarely move together. Understanding how they interact, and where they diverge, is where the commercially important answers live. That is why Spherix maintains three dedicated research communities rather than one.
Partnership, not transactions
AI accelerates expertise – it does not replace it
Spherix specialists provide the judgment behind every insight – interpreting, challenging, and validating what the data shows, and connecting the right respondents to the right study. AI simply gets them there faster: compressing the time between data collection and actionable insight, and running on proprietary datasets Spherix has built over more than a decade, not public sources.
LEADERSHIP
Seasoned experts at the helm
Meet the team
Our talented collaborators
Our community
See the market from the decision maker’s point of view.
Spherix's physician, payer, and patient communities represent curated groups of your targeted physicians and APPs, KOLs shaping your category, commercial and government payers making access decisions, executives from integrated delivery networks, and the patients who rely on your therapies. These relationships keep Spherix closely connected to the specific challenges and opportunities in every market it covers.
Vetted Practicing Providers
Key Opinion Leaders
Professional Organizations
Market Access Stakeholders